X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs ALEMBIC PHARMA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD ALEMBIC PHARMA WYETH LTD/
ALEMBIC PHARMA
 
P/E (TTM) x 27.7 23.0 120.3% View Chart
P/BV x 5.3 6.1 88.3% View Chart
Dividend Yield % 1.3 0.8 163.7%  

Financials

 WYETH LTD   ALEMBIC PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
ALEMBIC PHARMA
Mar-16
WYETH LTD/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs1,044792 131.9%   
Low Rs818443 184.7%   
Sales per share (Unadj.) Rs298.6167.0 178.8%  
Earnings per share (Unadj.) Rs57.238.2 150.0%  
Cash flow per share (Unadj.) Rs58.442.0 139.1%  
Dividends per share (Unadj.) Rs17.004.00 425.0%  
Dividend yield (eoy) %1.80.6 281.8%  
Book value per share (Unadj.) Rs249.584.9 293.8%  
Shares outstanding (eoy) m22.72188.52 12.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.13.7 84.4%   
Avg P/E ratio x16.316.2 100.6%  
P/CF ratio (eoy) x15.914.7 108.4%  
Price / Book Value ratio x3.77.3 51.3%  
Dividend payout %29.710.5 283.3%   
Avg Mkt Cap Rs m21,157116,383 18.2%   
No. of employees `0000.5NA-   
Total wages/salary Rs m4004,214 9.5%   
Avg. sales/employee Rs Th13,787.4NM-  
Avg. wages/employee Rs Th813.0NM-  
Avg. net profit/employee Rs Th2,643.3NM-  
INCOME DATA
Net Sales Rs m6,78331,487 21.5%  
Other income Rs m35355 639.9%   
Total revenues Rs m7,13631,542 22.6%   
Gross profit Rs m1,61710,060 16.1%  
Depreciation Rs m27722 3.7%   
Interest Rs m637 14.9%   
Profit before tax Rs m1,9389,356 20.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6322,160 29.3%   
Profit after tax Rs m1,3017,194 18.1%  
Gross profit margin %23.831.9 74.6%  
Effective tax rate %32.623.1 141.3%   
Net profit margin %19.222.8 83.9%  
BALANCE SHEET DATA
Current assets Rs m6,98415,066 46.4%   
Current liabilities Rs m2,0567,674 26.8%   
Net working cap to sales %72.623.5 309.5%  
Current ratio x3.42.0 173.0%  
Inventory Days Days9967 148.2%  
Debtors Days Days2441 58.9%  
Net fixed assets Rs m2448,237 3.0%   
Share capital Rs m227377 60.3%   
"Free" reserves Rs m5,44115,416 35.3%   
Net worth Rs m5,66816,005 35.4%   
Long term debt Rs m250-   
Total assets Rs m7,90124,594 32.1%  
Interest coverage x353.3255.2 138.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.3 67.1%   
Return on assets %16.529.4 56.2%  
Return on equity %22.944.9 51.0%  
Return on capital %34.058.7 58.0%  
Exports to sales %0.255.7 0.4%   
Imports to sales %36.310.4 348.6%   
Exports (fob) Rs m1517,551 0.1%   
Imports (cif) Rs m2,4653,283 75.1%   
Fx inflow Rs m1517,811 0.1%   
Fx outflow Rs m2,6775,318 50.3%   
Net fx Rs m-2,66212,493 -21.3%   
CASH FLOW
From Operations Rs m9239,304 9.9%  
From Investments Rs m317-3,105 -10.2%  
From Financial Activity Rs m-481-1,959 24.6%  
Net Cashflow Rs m7594,240 17.9%  

Share Holding

Indian Promoters % 0.0 74.1 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 2.9 389.7%  
FIIs % 7.2 9.1 79.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 13.9 218.7%  
Shareholders   21,978 49,328 44.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   GLENMARK PHARMA  FULFORD INDIA  MERCK LTD  DIVIS LABORATORIES  UNICHEM LAB  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 219 Points Lower; Energy and Auto Stocks Witness Selling(Closing)

After witnessing volatile trades during the day, Indian share markets ended their session on a negative note. Losses were largely seen in the oil & gas sector, auto sector.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS